Geftinat Medicines

Offering you a complete choice of products which include geftinat- indian iressa tablet, important side effects of gefticip and gefonib 250 mg tablet.

Geftinat- Indian Iressa Tablet

REQUEST CALLBACK

Ask for Price

Product Price :Get Latest Price

Empowered by our vast industry experience, we are engaged in providing our clients a broad range of Geftinat- Indian Iressa. Our offered Geftinat medicines are processed using quality assured ingredients & advance methodology by our skilled pharmaceutical experts. We are giving these Geftinat medicines in various packing options to meet the exact needs of the customers. These Geftinat medicines are used in the treatment of non-small cell lung cancer.

Features:

Safe packaging
Long shelf life
Balanced composition

Note: Geftinat is a prescription drug and should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.

Yes! I am interested

Important Side Effects of Gefticip

REQUEST CALLBACK

Ask for Price

Product Price :Get Latest Price

Description

Brand Name: Gefticip 250mg
Generic Name : Gefitinib Tablets
Contents: Gefitinib 250mg
Form: Tablets
Manufacturer: Cipla India Ltd
Other Brand Name: Iressa
Packing: Pack of 30 & 10 tabs

Note: Gefticip is a prescription Drug and should be used under Proper Medical Guidance and Advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.

Yes! I am interested

Gefonib 250 Mg Tablet

REQUEST CALLBACK

Ask for Price

Product Price :Get Latest Price

Our organization has gained recognition as a flourishing organization by offering Gefonib 250 Mg that is classified as a signal transduction inhibitor. Our Gefonib medicines are processed using excellent quality ingredients by our pharmaceutical experts in accordance with the set medical norms. These Gefonib medicines are indicated for the treatment of locally advanced or metastatic non-small cell lung cancer, after failure of both platinum-based and taxane-based chemotherapies.

Features: